NEWS & MEDIA

Archive: 2024

JPEO-CBRND Research Featured in Nature: World’s Leading Multidisciplinary Science Journal
May 8, 2024 — In a groundbreaking development for addressing future viral pandemics, an interagency team of researchers have successfully combined an artificial intelligence (AI)-backed platform to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by viral evolution. The accomplishment was published on May...

Around the World: JPEO-CBRND Gathers Global Data to Enhance Threat Detection Capabilities
April 15, 2024 — In recent years, the public has become more familiar with rapid biological diagnostic technologies for diseases due to the prevalence of at-home COVID-19 test kits and the 24-48-hour Polymerase Chain Reaction (PCR) tests completed in a laboratory. Developing effective tools like rapid COVID-19 tests takes a tremendous amount of performance data. As...

The People Behind the Mission: A Q&A with the staff of JPL CBRND Enabling Biotechnologies
March 22, 2024 — We caught up with some of our leading staff from the Joint Project Lead for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies (JPL CBRND EB), to learn about their role within the organization and their sources of inspiration. JPL CBRND EB is one of two JPLs within JPEO-CBRND. Its mission is to give the joint force...

JPEO-CBRND Featured in APG's The Proof Winter 2024
March 11, 2024 — The JPEO-CBRND has two features in the Winter 2024 edition of APG's The Proof Magazine. The full magazine focused on APG South's tenant commands and history of chemical and research and engineering. Find the full winter edition of the magazine online:...

AL&T Feature - Agile Acquisition for … Hardware?
March 7, 2024 — The interior of the Negatively Pressurized CONEX at the Center for Sustainment of Trauma and Readiness Skills in Omaha, Nebraska, in June 2023. The NPC was developed using methods typical of agile software development. (U.S. Air Force Photo)Read the full article about the JPM CBRN Protection's Negatively Pressurized Conex (NPC), which keeps...

GUIDE Program Prepares DOD to Defend Against the Unknown
February 27, 2024 — Significant biological events can take different shapes and sizes, from disease to intentional poisons and anywhere in between. COVID-19 taught the world firsthand that we likely will not know what the next threat is, but that any biological event can cause great harm to society and the world. To meet this reality, Joint Program Executive Office...

Department of Defense Transitions Legacy Special Immunization Program to Commercial Partners
February 16, 2024 — Some professions are inherently risky—and for military personnel, first responders, and medical providers, special precautions are required to safely perform their duties. The same holds true for people who study infectious diseases with the aim of developing medical countermeasures to protect U.S. troops and the general population.Fort Detrick’s...

CSC2 Moves Full Speed Ahead on the Software Acquisition Pathway
February 6, 2024 — Do you drive in a vehicle that has blind-spot warning indicators, adaptive cruise control or back-up cameras? Do you wear a smart watch or use a smart phone that integrates your entertainment, scheduling, location sharing, and warns you when you’ve been exposed to loud noises that could harm your hearing? If so, then you likely understand the power...

JPEO-CBRND Awards $235.8 Million Procurement Contract to Emergent Biosolutions to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the DOD
January 19, 2024 — On January 9, 2024, the U.S. Department of Defense (DOD) awarded an indefinite delivery/indefinite quantity (ID/IQ) procurement contract to Emergent BioSolutions, Inc. to supply the U.S. Food and Drug Administration (FDA)-approved BioThrax® (Anthrax Vaccine Adsorbed), a pre-exposure prophylaxis (PrEP) for anthrax disease, for use by all branches of...

Joint Industry Day Event Inspires Collaboration and Trust in the Fight Against Chemical Nerve Agent Threats
January 3, 2024 — Medical countermeasures (MCMs) are the first line of defense against novel weapons of mass destruction (WMD) threats, and discussions surrounding the development of improved chemical agent MCM capabilities took center stage at the “Reactivators and Multi-Drug Autoinjector Industry Day” event held on 1-2 November in McLean, Virginia. U.S. government...

News Search

News Archive - Search by Year and Month

CPE CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the CPE CBRND's Capabilities Catalog, Leadership Biographies, and contracting overview documents.

CPE CBRND Public Affairs Office

The CPE CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the CPE CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the CPE CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the CPE CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.